Literature DB >> 15919789

Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes.

Seung-Soon Im1, Seung-Youn Kang, So-Youn Kim, Ha-Il Kim, Jae-Woo Kim, Kyung-Sup Kim, Yong-Ho Ahn.   

Abstract

GLUT2 is mainly expressed in the liver, beta-cells of the pancreas, and the basolateral membrane of kidney proximal tubules and plays an important role in glucose homeostasis in living organisms. The transcription of the GLUT2 gene is known to be upregulated in the liver during postprandial hyperglycemic states or in type 2 diabetes. However, a molecular mechanism by which glucose activates GLUT2 gene expression is not known. In this study, we report evidence that sterol response element-binding protein (SREBP)-1c plays a key role in glucose-stimulated GLUT2 gene expression. The GLUT2 promoter reporter is activated by SREBP-1c, and the activation is inhibited by a dominant-negative form of SREBP-1c (SREBP-1c DN). Adenoviral expression of SREBP-1c DN suppressed glucose-stimulated GLUT2 mRNA level in primary hepatocytes. An electrophoretic mobility shift assay and mutational analysis of the GLUT2 promoter revealed that SREBP-1c binds to the -84/-76 region of the GLUT2 promoter. Chromatin immunoprecipitation revealed that the binding of SREBP-1c to the -84/-76 region was increased by glucose concentration in a dose-dependent manner. These results indicate that SREBP-1c mediates glucose-stimulated GLUT2 gene expression in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919789     DOI: 10.2337/diabetes.54.6.1684

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

1.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4.

Authors:  Jose M Arbones-Mainar; Lance A Johnson; Michael K Altenburg; Hyung-Suk Kim; Nobuyo Maeda
Journal:  FASEB J       Date:  2010-05-25       Impact factor: 5.191

3.  The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.

Authors:  Amandeep Singh; Phuc Le; Rocio Lopez; Naim Alkhouri
Journal:  Hepatol Int       Date:  2018-01-09       Impact factor: 6.047

4.  Anti-diabetic effects of mulberry (Morus alba L.) branches and oxyresveratrol in streptozotocin-induced diabetic mice.

Authors:  Eunyeong Ahn; Jimin Lee; Young-Hee Jeon; Sang-Won Choi; Eunjung Kim
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

Review 5.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

6.  Effects of octreotide on glucose transporter type 2 expression in obese rat small intestine.

Authors:  Na Wei; Rui Liu; Yan Ou; Xian Li; Ou Qiang; Wei Guo; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

7.  Regulation of GLUT4 gene expression by SREBP-1c in adipocytes.

Authors:  Seung-Soon Im; Sool-Ki Kwon; Seung-Youn Kang; Tae-Hyun Kim; Ha-Il Kim; Man-Wook Hur; Kyung-Sup Kim; Yong-Ho Ahn
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

8.  TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.

Authors:  B A Di Bartolo; J Chan; M R Bennett; S Cartland; S Bao; B E Tuch; M M Kavurma
Journal:  Diabetologia       Date:  2011-10-01       Impact factor: 10.122

9.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

10.  E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis.

Authors:  Pierre-Damien Denechaud; Isabel C Lopez-Mejia; Albert Giralt; Qiuwen Lai; Emilie Blanchet; Brigitte Delacuisine; Brandon N Nicolay; Nicholas J Dyson; Caroline Bonner; François Pattou; Jean-Sébastien Annicotte; Lluis Fajas
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.